Expert Insights

In this commentary, Laurie Keefer, PhD, AGAF, from the Icahn School of Medicine at Mount Sinai in New York, challenges gastroenterologists to take a more holistic view of their patients with inflammatory bowel disease, and to look beyond clinical signs and symptoms to the question of whether the patient is living well.
In this video Dr Knotts, from NYU-Langone Health's Center for Esophageal Health, discusses eosinophilic esophagitis, including its distinction from gastroesophageal reflux disease and how proton pump inhibitors have progressed from use as a diagnostic tool to a treatment for eosinophilic esophagitis.
Dr Feuerstein chaired the guideline panel that developed the American Gastroenterological Association's new guidelines on managing ulcerative colitis. He sat down with Gastroenterology Learning Network to answer a few questions.
In this video Dr Catana, with Beth Israel Deaconess Medical Center in Boston, provides highlights of presentations and panel discussions at the American Association for the Study of Liver Diseases meeting on hepatocellular carcinoma.
Dr Long, professor of medicine at the University of North Carolina at Chapel Hill, discusses her presentation at the Advances in Inflammatory Bowel Disease 2020 virtual meeting on how data from both clinical trials and real-world practice can help clinicians make the best choices for therapies for their patients with IBD.
In this article, Dr Afghani, from Johns Hopkins University School of Medicine in Baltimore, Maryland, and Section Editor of Pancreatic Diseases and Disorder for Gastroenterology Learning Network, gives an overview of the relationship between pancreatitis and pancreatic cancer, and how gastroenterologists can stratify patients who may be at risk of developing pancreatic cancer.
In this video, Michael Chiorean, MD, reviews how JAK inhibitors, IL-12/23 inhibitors, and other, newer therapies are expanding the tools for management of ulcerative colitis.
Dr Kane, professor of medicine at the Mayo Clinic in Rochester, Minnesota, reviews her presentation at the AIBD 2020 virtual meeting on how best to inform and educate patients with inflammatory bowel disease to help ensure good outcomes.
In this video, Dr. Dubinsky, codirector of the Susan and Leonard Feinstein IBD Center at the Icahn School Medicine at Mount Sinai in New York, reviews a panel discussion on therapeutic monitoring of anti-TNF levels in patients with inflammatory bowel disease, presented December 11 at AIBD 2020.
In this video, Dr Kornbluth, of the Icahn School of Medicine at Mount Sinai in New York, reviews his presentation from AIBD 2020 on the importance of careful surveillance for dysplasia and follow-up with patients with inflammatory bowel disease.